metabolic disruption

Pyraclostrobin is one of the most heavily used fungicides that inhibits mitochondrial complex III of fungal and mammalian cells.

Anti-MRSA agent 33 iodide is an effective anti-methicillin-resistant Staphylococcus aureus (MRSA) compound with a minimum inhibitory concentration (MIC) of 2-4 μg/mL. It demonstrates significant biofilm eradication capability and exhibits very low cytotoxicity to mammalian cells. The compound specifically binds to phosphatidylglycerol (PG) on bacterial membranes, leading to membrane disruption, excessive reactive oxygen species (ROS) production, and metabolic collapse, which ultimately result in bacterial cell death. In a murine skin infection model, Anti-MRSA agent 33 iodide effectively reduced bacterial load.

KHK-2898 represents a highly specialized humanized monoclonal antibody specifically engineered to target the CD98 heavy chain (CD98hc/SLC3A2) with exceptional binding affinity to the human and monkey LAT1/CD98hc complex. It effectively facilitates the measurable blockade of amino acid transport and the induction of potent antibody-dependent cellular cytotoxicity (ADCC) across various preclinical experimental models to evaluate the disruption of tumor nutrient uptake and metabolic homeostasis during strictly monitored laboratory observation periods and functional cell viability assays.

Dammarenediol II may exert protective effects against diabetic microvascular complications, including diabetic retinopathy, by potently inhibiting vascular endothelial growth factor (VEGF)-induced intracellular reactive oxygen species generation, stress fiber formation, and vascular endothelial cadherin disruption. Dammarenediol II preserves endothelial integrity, this medicinally important triterpenoid can be ectopically produced in tobacco, where dammarenediol II biosynthesis enables plants to adopt a virus-resistance defense system, supporting its relevance in metabolic disease research, vascular biology, and plant-based bioproduction strategies.